Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Aug 2016

Ren Xinyu, Yuan Li, Shen Songjie, Wu Hanwen, Lu Junliang, Liang Zhiyong

Abstract excerpt

Basal-like breast cancer (BLBC) and triple-negative breast cancer (TNBC) are two entities of breast cancer that share similar poor prognosis. Even though both cancers have overlaps, there are still some differences between those two types. It has been reported that the c-Met high expression was associated with poor prognosis not only in breast cancer but also in many other cancers. The role of ERβ in pathogenesis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Estrogen Receptor beta

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Kaplan-Meier Estimate

Share to Prognosis

Share to Proportional Hazards Models

Share to Proto-Oncogene Proteins c-met

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 26968553
DOI: 10.1007/s13277-016-5010-5

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.PMID 26968553Read ↗

[Basal-like breast cancers: clinicopathological features and outcome].Semantic proximity Read ↗

Basal phenotype breast cancer: implications for treatment and prognosis.Semantic proximity Read ↗

Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women.Semantic proximity Read ↗

Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative Breast CancerSemantic proximity Read ↗

What Is the Difference Between Triple-Negative and Basal Breast Cancers?Semantic proximity Read ↗

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.Semantic proximity Read ↗

Targeting basal-like breast cancers.Semantic proximity Read ↗

Prognostic Significance of Combining Cytokeratin-19, E-Cadherin and Ki-67 Analysis in Triple-Negative Breast Cancer with Basal-Like and Non-Basal-Like Phenotype.Semantic proximity Read ↗

Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.Semantic proximity Read ↗

Basal-like Breast Carcinoma: From Expression Profiling to Routine PracticeSemantic proximity Read ↗

Basal-Like Breast Cancer: A Critical ReviewSemantic proximity Read ↗

Characteristics of the clinicopathology and immune microenvironment of the basal-like phenotype in HR+/HER2-breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.